These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 3618658)
21. Inhibitory control in children with phenylketonuria. Christ SE; Steiner RD; Grange DK; Abrams RA; White DA Dev Neuropsychol; 2006; 30(3):845-64. PubMed ID: 17083296 [TBL] [Abstract][Full Text] [Related]
22. Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Welsh MC; Pennington BF; Ozonoff S; Rouse B; McCabe ER Child Dev; 1990 Dec; 61(6):1697-713. PubMed ID: 2083493 [TBL] [Abstract][Full Text] [Related]
23. Phenylalanine hydroxylase deficiency: intelligence of patients after early dietary treatment. Chien YH; Chiang SC; Huang A; Lin JM; Chiu YN; Chou SP; Wang TR; Hwu WL Acta Paediatr Taiwan; 2004; 45(6):320-3. PubMed ID: 15868846 [TBL] [Abstract][Full Text] [Related]
24. Neonatal hyperviscosity association with lower achievement and IQ scores at school age. Delaney-Black V; Camp BW; Lubchenco LO; Swanson C; Roberts L; Gaherty P; Swanson B Pediatrics; 1989 May; 83(5):662-7. PubMed ID: 2717281 [TBL] [Abstract][Full Text] [Related]
25. [An adult patient with phenylketonuria before and one year after reinstitution of diet therapy]. Tiefenthaler M; Seidl R; Scheibenreiter S; Wandl-Vergesslich K; Stöckler-Ipsiroglu S Wien Klin Wochenschr; 1999 Jan; 111(1):33-6. PubMed ID: 10067268 [TBL] [Abstract][Full Text] [Related]
26. [Intellectual development after relaxing the diet at the age of 5 years in typical phenylketonuria]. Abadie V; Rey F; Plainguet F; Rey J Arch Fr Pediatr; 1992 Nov; 49(9):773-8. PubMed ID: 1300964 [TBL] [Abstract][Full Text] [Related]
27. Intellectual assessment of 111 four-year-old children with phenylketonuria. Dobson JC; Williamson ML; Azen C; Koch R Pediatrics; 1977 Dec; 60(6):822-7. PubMed ID: 600594 [TBL] [Abstract][Full Text] [Related]
28. [The interaction of biological and social factors on the effect of treatment in cases of phenylketonuria (author's transl)]. Wässer S; Theile H Padiatr Padol; 1981; 16(4):417-26. PubMed ID: 7301389 [TBL] [Abstract][Full Text] [Related]
29. Speech and language skills in children with early treated phenylketonuria. Ozanne AE; Krimmer H; Murdoch BE Am J Ment Retard; 1990 May; 94(6):625-32. PubMed ID: 2340139 [TBL] [Abstract][Full Text] [Related]
30. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome. Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659 [TBL] [Abstract][Full Text] [Related]
31. Pre-academic and early academic achievement in children with velocardiofacial syndrome (del22q11.2) of borderline or normal intelligence. De Smedt B; Swillen A; Ghesquière P; Devriendt K; Fryns JP Genet Couns; 2003; 14(1):15-29. PubMed ID: 12725586 [TBL] [Abstract][Full Text] [Related]
32. Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Anastasoaie V; Kurzius L; Forbes P; Waisbren S Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366 [TBL] [Abstract][Full Text] [Related]
33. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria. Sharman R; Sullivan K; Young R; McGill J Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250 [TBL] [Abstract][Full Text] [Related]
34. [Neurological status and psychomotor development of children with phenylketonuria treated early]. Czochańska J; Wilmowska-Pietruszyńska A; Zorska K; Cabalska B Probl Med Wieku Rozwoj; 1979; 8():77-83. PubMed ID: 263530 [TBL] [Abstract][Full Text] [Related]
35. [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia]. Schwarz HP; Plüss C; Triaca H; Schütz B; Kaufmann R; Scherz R; Bachmann C; Zuppinger K Schweiz Med Wochenschr; 1988 Jan; 118(3):94-9. PubMed ID: 3344414 [TBL] [Abstract][Full Text] [Related]
36. Maternal phenylketonuria: an international study. Koch R; Hanley W; Levy H; Matalon R; Rouse B; Trefz F; Guttler F; Azen C; Friedman E; Platt L; de la Cruz F Mol Genet Metab; 2000; 71(1-2):233-9. PubMed ID: 11001815 [TBL] [Abstract][Full Text] [Related]
37. School performance in early and continuously treated phenylketonuria. Gassió R; Fusté E; López-Sala A; Artuch R; Vilaseca MA; Campistol J Pediatr Neurol; 2005 Oct; 33(4):267-71. PubMed ID: 16194725 [TBL] [Abstract][Full Text] [Related]
38. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Diamond A; Prevor MB; Callender G; Druin DP Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921 [TBL] [Abstract][Full Text] [Related]
39. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640 [TBL] [Abstract][Full Text] [Related]
40. [Intellectual development of phenylketonuria children treated early--a longitudinal study. 10 years' concomitant psychological study in The Netherlands]. Slijper FM; Huisman J; Hendrikx MM; Kalverboer AF; van der Schot L Monatsschr Kinderheilkd; 1989 Oct; 137(10):662-5. PubMed ID: 2586531 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]